Brompheniramine

Pediatric
  • TRADE NAMES: Bromfed (Muro); Bromine; Brommine; Bromphen; Dimegan; Dimetane; Ilvin; Kinmedon; Nasahist; ND-Stat; Neo-Meton; Rondec (Biovail)
  • INDICATIONS: Allergic rhinitis, urticaria
  • CLASS: Histamine H1 receptor antagonist
  • HALF-LIFE: 12–48 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Aprobarbital, Butabarbital, Chloral Hydrate, Ethchlorvynol, Mephobarbital, Pentobarbital, Phenobarbital, Phenothiazines, Primidone, Secobarbital, Zolpidem

PREGNANCY CATEGORY: C

Our database has 9 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
NEUROMUSCULAR/SKELETAL.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top